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ABSTRACT
Background and Objectives: Recent studies have examined the structure-function 
relationship of high-density lipoprotein (HDL). This study aimed to identify and rank HDL-
associated proteins involved in several biological function of HDL.
Methods: HDLs isolated from 48 participants were analyzed. Cholesterol efflux capacity, 
effect of HDL on nitric oxide production, and vascular cell adhesion molecule-1 expression 
were assessed. The relative abundance of identified proteins in the highest vs. lowest quartile 
was expressed using the normalized spectral abundance factor ratio.
Results: After adjustment by multiple testing, six proteins, thyroxine-binding globulin, 
alpha-1B-glycoprotein, plasma serine protease inhibitor, vitronectin, angiotensinogen, and 
serum amyloid A-4, were more abundant (relative abundance ratio ≥2) in HDLs with the 
highest cholesterol efflux capacity. In contrast, three proteins, complement C4-A, alpha-
2-macroglobulin, and immunoglobulin mu chain C region, were less abundant (relative 
abundance ratio <0.5). In terms of nitric oxide production and vascular cell adhesion molecule-1 
expression, no proteins showed abundance ratios ≥2 or <0.5 after adjustment. Proteins 
correlated with the functional parameters of HDL belonged to diverse biological categories.
Conclusions: In summary, this study ranked proteins showing higher or lower abundance 
in HDLs with high functional capacities and newly identified multiple proteins linked to 
cholesterol efflux capacity.
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INTRODUCTION
Numerous recent studies have revealed the functions of high-density lipoprotein (HDL), 
which include roles in lipid transport, inflammation, and immunity.1) To date, diverse HDL-
associated proteins have been identified. Their functional categories include proteolysis, 
complement, coagulation, and lipid transport, among others, where they are thought to be 
involved in biological functions.2)
Several studies have shown that HDL function is disturbed under pathological conditions, 
and a remodeled HDL proteome may contribute to the observed functional changes. 
For example, the HDL proteome in patients with coronary artery disease is altered and 
can activate a proapoptotic pathway in endothelial cells.3) In patients with end-stage 
renal disease, the proteome is remodeled to contain more proteins belonging to acute 
phase reactants or the immune response.4) Recently, researchers have investigated the 
structure-function relationship of HDL in more detail. Particularly, HDL proteins including 
apolipoprotein A1 (apoA1) were shown to be involved in various biological functions.5) 
Riwanto et al.3) demonstrated that apoJ promoted an antiapoptotic pathway, while apoC3 
activated the opposite signaling pathway in endothelial cells. In addition, apoL1, paraoxonase 
1, and paraoxonase 3, carried by HDL3c, were reported to have anti-oxidant effects.6)
An optimized method for assessing HDL function has not been established. Cholesterol 
efflux capacity is the best-known index for HDL function, while endothelial nitric oxide 
(NO) production and vascular cell adhesion molecule (VCAM)-1 expression are often 
measured to evaluate the anti-inflammatory functions of HDL.7) Semi-quantitative 
proteomic analysis has been used to evaluate heterogeneous HDL particles.8) Thus, the aim 
of our study was to identify and rank HDL-associated proteins involved in representative 
HDL functions. We performed proteomic analysis to compare HDL-associated proteins 
in pooled samples according to cholesterol efflux capacity, NO production, and VCAM-1 
expression by HDL.
METHODS
Study participants
Forty-eight patients with diverse cardiovascular risks were recruited for this study. Diverse 
health conditions may influence the composition and functions of HDL, and differences 
between HDL are needed for appropriate analysis of our study. Therefore, we included 
patients with various cardiovascular risk factors, unless they were in uncontrolled status 
(Supplementary Data 1). The study protocol was approved by the Institutional Review 
Board of Severance Hospital, Seoul, Korea (number 4-2013-0281). The investigation was 
conducted according to the principles stated in the Declaration of Helsinki. All participants 
provided written, informed consent. All patients enrolled in the study were statin-naïve or 
had discontinued prior lipid lowering agents for at least 3 months. Only patients without 
history of cardiovascular disease were eligible for wash-out of prior agents. Patients 
enrolled in this study and had coronary artery disease were all diagnosed for the first time 
and statin-naïve. Exclusion criteria are described in the Supplementary Data 1. At the 
time of enrollment, the patients were interviewed to obtain medical histories, followed by 
laboratory assessment.
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Blood sampling and isolation of high-density lipoprotein
The patients were instructed to fast and avoid drinking alcoholic beverages or smoking for 
≥12 hours before the collection of blood samples, which were analyzed within 4 hours. Lipid 
levels were analyzed using an auto-analyzer at a local laboratory certified by the Korean 
Society of Laboratory Medicine. HDL was isolated by ultracentrifugation as described in the 
Supplementary Data 1.
Tests of high-density lipoprotein function
Measurement of cholesterol efflux capacity, NO production, and VCAM-1 expression is 
described in the Supplementary Data 1.
Sample preparation
For proteomic analysis, HDL samples were pooled into equal amounts according to the highest 
and lowest quartiles of cholesterol efflux capacity, NO production, and VCAM-1 levels. Before 
mass spectral analysis, 80 μg of each pooled HDL sample was separated based on molecular 
weight in a NuPAGE gel (4–12% Bis-Tris gel; Invitrogen, Carlsbad, CA, USA). Methods for 
sample preparation and in-gel digestion are described in the Supplementary Data 1.
Mass spectral analysis
Ten microliters of each sample were injected into a reversed-phase Magic C18AQ column 
(15 cm × 75 µm) on an Eksigent MDLC system (Eksigent Technologies, Dublin, CA, USA). 
The nano HPLC system was coupled to an LTQ XL-Orbitrap mass spectrometer (Thermo 
Scientific, Waltham, MA, USA). Each liquid chromatography-mass spectrometry (MS)/
MS file was analyzed using the SEQUEST algorithm in Proteome Discoverer 1.4 (Thermo 
Scientific). MS and MS/MS data were searched against the SwissProt human database 
(August 2016) with 20121. Detailed methods used for mass spectral analysis are available in 
the Supplementary Data 1.
Label-free quantitative analysis
The relative abundances of the proteins identified in pooled HDL samples showing the 
highest and lowest quartile values of cholesterol efflux capacity, NO production, and VCAM-
levels were calculated based on the normalized spectral abundance factor (NSAF). Spectral 
count data (number of MS/MS spectra matched to the protein) were first extracted using 
Proteome Discoverer 1.4 software and exported into MS-EXCEL. The NSAF for each protein 
was calculated as follows:
in which the total number of MS/MS spectra matching peptides from protein k (SpC) was 
divided by protein length (L) and then divided by the sum of SpC/L for all N proteins.
For statistical analysis of the dataset, natural logarithm of each NSAF value was calculated, 
followed by Student's t-test of ln(NSAF) values obtained from the three replicates of the 
highest and lowest quartile values of each parameter. For the proteins showing relative 
abundance ratio >2 depending on three functional properties of HDL, Benjamini and 
Hochberg method-based false discovery ratio (FDR)-adjusted p values were calculated. A 
p value <0.05 was considered statistically significant. Additional analytical methods are 
described in the Supplementary Data 1.
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RESULTS
Characteristics of study subjects
The demographic data of the study subjects are presented in Table 1. Of the 48 patients, 
34 (71%) were male, with patient ages ranging from 30 to 80 years. The mean high-density 
lipoprotein-cholesterol (HDL-C) level was 45.7±13.2 mg/dL, whereas the mean low-density 
lipoprotein-cholesterol (LDL-C) level was 127±32 mg/dL. Patients with the highest quartile 
value of cholesterol efflux were younger and showed higher total- and LDL-C levels than 
those with the lowest quartile value. The characteristics and lipid profiles of the patients with 
the highest and lowest quartile values for NO production and VCAM-1 expression were not 
significantly different. Test results of each functional parameter according to quartile groups 
are presented in Figure 1.
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Table 1. Clinical characteristics of the study subjects
Variables Cholesterol efflux capacity NO production VCAM-1 expression
Highest (n=12) Lowest (n=12) p Highest (n=11) Lowest (n=11) p Highest (n=8) Lowest (n=8) p
Age (years) 53.9±9.8 61.2±7.0 0.046 58.1±7.9 56.4±12.6 0.70 57.0±13.3 55.0±10.7 0.75
Male 7 (58) 8 (67) 1.00 6 (55) 10 (91) 0.15 4 (50) 8 (100) 0.08
Medical history
Hypertension 8 (67) 3 (25) 0.10 6 (55) 6 (55) 1.00 4 (50) 4 (50) 1.00
Diabetes mellitus 1 (8) 0 (0) 1.00 1 (9) 2 (18) 1.00 0 (0) 0 (0) 1.00
Hypercholesterolemia 3 (25) 0 (0) 1.00 2 (18) 2 (18) 1.00 1 (13) 2 (25) 1.00
Smoking 3 (25) 2 (17) 1.00 3 (27) 5 (46) 1.00 0 (0) 4 (50) 0.08
Coronary artery disease 2 (17) 9 (75) 0.01 4 (36) 3 (27) 1.00 2 (25) 5 (63) 0.31
Laboratory values (mg/dL)
Total cholesterol 227±42 192±30 0.04 227±41 208±35 0.27 202±37 225±48 0.32
Triglyceride 186 (111, 259) 180 (101, 212) 0.42 177 (95, 257) 184 (155, 235) 0.75 148 (112, 200) 169 (113, 432) 0.42
HDL-C 48.0 (38.5, 52.5) 43.7 (40.0, 49.0) 0.34 48.0 (43.0, 56.0) 36.0 (32.5, 46.2) 0.12 54.0 (44.7, 54.5) 45.5 (38.0, 50.0) 0.12
LDL-C 141±33 114±28 0.047 133±36 131±33 0.89 121±29 127±46 0.78
Variables are expressed as medians (25th percentile, 75th percentile) or number (%).
HDL-C = high-density lipoprotein-cholesterol; LDL-C = low-density lipoprotein-cholesterol; NO = nitric oxide; VCAM = vascular cell adhesion molecule.
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Figure 1. Results of each functional parameter of HDL according to quartile groups. Values of cholesterol efflux capacity (A), NO production (B), and VCAM-1 
expression (C). 
HDL = high-density lipoprotein; NO = nitric oxide; VCAM = vascular cell adhesion molecule.
Identification of HDL proteins associated with cholesterol efflux capacity, 
nitric oxide production, and vascular cell adhesion molecule-1 expression
For proteomic analysis, 80 μg of each HDL sample pooled according to the highest and 
lowest quartile values of the functional parameters was separated based on molecular 
weight. In-gel tryptic digestion of the stained protein bands was performed to identify 
the proteins. Through mass spectral analysis of the extracted peptides from each pooled 
HDL sample, 213, 184, and 199 proteins were identified, as shown in the Venn diagrams in 
Supplementary Figure 1.
Differential abundance of high-density lipoprotein proteins associated with 
cholesterol efflux capacity
Label-free quantification based on the spectral count was performed to identify HDL-
associated proteins that were differentially abundant in samples with high functional 
parameter values. Only proteins with p<0.05 are shown in Figures 2-4. Table 1 lists the 
proteins that were highly ranked according to their differential abundance (relative 
abundance ratios ≥2 or ≤0.5, p value <0.05 from Student's t-test) in HDL with the 
highest quartile for each parameter. The spectral count and relative abundance ratios 
of all differentially abundant proteins (p value <0.05 from Student's t-test) are listed in 
Supplementary Tables 1-3. The functional categories of the proteins were classified and are 
presented in Supplementary Tables 4-6.
Twenty-seven proteins were more abundant and 33 were less abundant in HDL with the 
highest quartile compared to in HDL with the lowest quartile of cholesterol efflux capacity 
(Figure 2 and Supplementary Table 1). Fourteen proteins showed relative abundance 
ratios ≥2. However, when the p values were adjusted by multiple testing, only 6 proteins, 
thyroxine-binding globulin, alpha-1B-glycoprotein, plasma serine protease inhibitor, 
vitronectin, angiotensinogen, and serum amyloid A-4 (SAA4), met the criteria. In contrast, 
14 proteins showed relative abundance ratios <0.5. After FDR adjustment by Benjamini 
and Hochberg method, only 3 proteins, complement C4-A, alpha-2-macroglobulin, and 
immunoglobulin mu chain C region, met the criteria (Table 1). When proteins that were 
more abundant in HDL with highest cholesterol efflux capacity were classified by functional 
categories, those belonging to “lipid metabolism” were most common. Among proteins 
less abundant in the same sample, those belonging to “immunity” were most common 
(Supplementary Table 4).
Differential abundance of high-density lipoprotein proteins associated with 
nitric oxide production
Nineteen proteins were significantly more abundant and seven were less abundant in HDL 
with the highest versus lowest quartile of NO production (Figure 3 and Supplementary 
Table 2). Four proteins showed relative abundance ratios ≥2. In contrast, no proteins showed 
relative abundance ratios of <0.5. When the p-values were adjusted by multiple testing, no 
proteins showed abundance ratios ≥2 or <0.5 (Table 2). The functional categories of proteins 
showing higher or lower abundance in HDL with high NO production varied considerably 
(Supplementary Table 5).
Differential abundance of high-density lipoprotein proteins associated with 
vascular cell adhesion molecule-1 expression
Fifteen proteins were significantly more abundant and nine were less abundant in HDL with 
the highest quartile than in HDL with the lowest quartile of VCAM-1 expression (Figure 4 and 
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Figure 2. Proteins ranked by their differential abundance in HDL with high cholesterol efflux capacity. The ranking 
was determined by the NSAF ratio, which is log2-transformed in the figure. 
HDL = high-density lipoprotein; NSAF = normalized spectral abundance factor.
Supplementary Table 3). Three proteins showed relative abundance ratios ≥2. Six proteins 
showed relative abundance ratios <0.5. After adjusting the p values, no proteins showed 
abundance ratios of ≥2 or <0.5 (Table 1). When the proteins that were more abundant in HDL 
showing high VCAM-1 expression were classified by functional categories, those belong to 
“immunity” were most common (Supplementary Table 6).
7/12https://e-kcj.org https://doi.org/10.4070/kcj.2019.0195
Related Proteins and HDL Functions
CPB2
Log2 (NSAF ratio)
HBD
QSOX1
LBP
C6
SERPINA7
SERPINF1
A1BG
SERPINC1
HP
HBB
PLG
VTN
F2
ITIH4
AGT
LPA
C4B
APOE
TF
ITIH2
ITIH1
APOD
APOH
IGFALS
APOA2
−1.0 −0.5 0 0.5 1.0 1.5 2.0 2.5 3.0
Figure 3. Proteins ranked by their differential abundance in HDL inducing high NO production. Ranking was 
determined by NSAF ratio, which is log2-transformed in the figure. 
HDL = high-density lipoprotein; NO = nitric oxide; NSAF = normalized spectral abundance factor.
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Figure 4. Proteins ranked by their differential abundance in HDL inducing high VCAM-1 expression levels. Ranking 
was determined by NSAF ratio, which is log2-transformed in the figure. 
HDL = high-density lipoprotein; NSAF = normalized spectral abundance factor; VCAM = vascular cell adhesion molecule.
DISCUSSION
In the present study, we identified and ranked HDL proteins associated with three functional 
parameters by comparing HDL samples with the highest and lowest values. Proteins belonging 
to diverse functional categories, including lipid metabolism and immunity, showed different 
abundances in HDL with high cholesterol efflux or anti-inflammatory effects. Notably, we 
identified several protein-function relationships associated with the effects of HDL that 
have not been reported previously. For example, after adjustment of the p-values, significant 
associations were observed between nine proteins and cholesterol efflux.
Researchers have reported relationship between abundance of several HDL-associated 
proteins and cholesterol efflux capacity. Gordon et al.9) and Pamir et al.10) identified several 
porteins such as apoA1, Gelsolin, antithrombin-III, apoE, and plasminogen as determinants 
of this capacity. Some proteins including complement C39) or apoC311) showed negative 
relationships to cholesterol efflux capacity. However, the relationships have not been 
consistent among all studies.12)
Vitronectin is known to play a role in proteolysis, hemostasis, and complement 
regulation.13)14) In the present study, this protein was found to be associated with high 
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Table 2. Relative abundance ratios and functional categories of proteins highly ranked according to their differential abundance (NSAF ratio ≥2 or ≤0.5) in HDL with 
high cholesterol efflux, NO production, or VCAM-1 expression
Gene name Protein description
NSAF ratio 
(highest/
lowest)
p Adjusted p Gene name Protein description
NSAF ratio 
(highest/
lowest)
p Adjusted p
Proteins more abundant in HDL with high cholesterol efflux capacity Proteins less abundant in HDL with high cholesterol efflux capacity
ECM1 Extracellular matrix protein 1 38.05 0.01 0.07 C4A Complement C4-A <0.001 <0.001 0.03
CPB2 Carboxypeptidase B2 9.37 0.03 0.13 A2M Alpha-2-macroglobulin 0.02 0.003 0.044
SERPINF1 Pigment epithelium-derived factor 9.03 0.02 0.12 HBD Hemoglobin subunit delta 0.02 0.01 0.053
IGFBP3 Insulin-like growth factor-binding protein 
3
7.22 0.01 0.07 C4BPA C4b-binding protein alpha chain 0.07 0.04 0.15
SERPINA7 Thyroxine-binding globulin 7.22 0.001 0.03 ATRN Attractin 0.10 0.004 0.052
SAA1 Serum amyloid A-1 protein 6.78 0.02 0.12 CPN2 Carboxypeptidase N subunit 2 0.13 0.01 0.06
A1BG Alpha-1B-glycoprotein 5.06 0.002 0.048 IGKV1-17 Ig kappa chain V-I region WEA 0.17 0.02 0.11
SERPINA5 Plasma serine protease inhibitor 3.94 0.003 0.045 IGHM Ig mu chain C region 0.20 0.002 0.048
F10 Coagulation factor X 3.60 0.03 0.14 C1R Complement C1r subcomponent 0.23 0.02 0.11
VTN Vitronectin 3.29 0.01 0.048 C1QB Complement C1q subcomponent subunit B 0.34 0.01 0.054
LPA Apolipoprotein(a) 2.63 0.01 0.054 PRG4 Proteoglycan 4 0.39 0.04 0.15
AGT Angiotensinogen 2.51 0.002 0.03 HBA1 Hemoglobin subunit alpha 0.43 0.02 0.08
SAA4 Serum amyloid A-4 protein 2.32 0.004 0.048 C5 Complement C5 0.44 0.02 0.11
SERPINF2 Alpha-2-antiplasmin 2.09 0.01 0.053 IGHA1 Ig alpha-1 chain C region 0.45 0.01 0.09
Proteins more abundant in HDL with high NO production Proteins less abundant in HDL with high NO production
CPB2 Carboxypeptidase B2 6.34 0.04 0.27
HBD Hemoglobin subunit delta 4.90 0.03 0.26
QSOX1 Sulfhydryl oxidase 1 4.52 0.03 0.26
LBP Lipopolysaccharide-binding protein 2.78 0.002 0.13
Proteins more abundant in HDL with high VCAM-1 expression Proteins less abundant in HDL with high VCAM-1 expression
QSOX1 Sulfhydryl oxidase 1 22.91 0.02 0.26 IGFBP3 Insulin-like growth factor-binding protein 3 0.12 0.049 0.69
GP1BA Platelet glycoprotein Ib alpha chain 9.16 0.02 0.69 CETP Cholesteryl ester transfer protein 0.20 0.002 0.52
F13B Coagulation factor XIII B chain 3.57 0.004 0.71 SERPINA7 Thyroxine-binding globulin 0.22 0.003 0.26
HLA-A HLA class I histocompatibility antigen, A-24 
alpha chain
0.33 0.03 0.69
SERPINF1 Pigment epithelium-derived factor 0.35 0.01 0.31
ECM1 Extracellular matrix protein 1 0.35 0.001 0.69
For the proteins showing the relative abundance ratios ≥2 depending on three functional properties of HDL, the Benjamini and Hochberg method-based false 
discovery rate-adjusted p values were calculated.
HDL = high-density lipoprotein; NO = nitric oxide; NSAF = normalized spectral abundance factor; VCAM = vascular cell adhesion molecule.
cholesterol efflux capacity, with a relative abundance ratio of 3.29. Vitronectin has been 
reported to be more enriched in HDL from the control group than from patients with 
coronary artery disease.15) However, the association between cholesterol efflux and 
vitronectin has not been demonstrated previously. Further mechanistic investigations are 
required to understand the biological role of HDL-associated vitronectin.
Our data revealed a positive association between SAA4 and cholesterol efflux. SAA4 is known 
to be present in HDL.15) SAA has been reported to induce cellular lipid release and HDL 
generation, both in an ATP-binding cassette transporter A1 (ABCA1)-dependent and ABCA1-
independent manner.16)17) In addition, SAA was suggested to promote cholesterol efflux 
via SR-B1.18) Our results provide insight into the association between SAA abundance and 
cholesterol efflux. However, this protein is also known to have a proinflammatory effect.19)
Several studies have examined the proteins evaluated in our study, providing insights into 
their roles. We observed that insulin-like growth factor-binding protein 3 (IGFBP3) in HDL 
was marginally associated with high cholesterol efflux capacity. Many, but not all, previous 
studies showed that IGFBP3 levels are positively correlated with blood HDL-C levels.20)21) 
However, the relationship between IGFBP3 and cholesterol efflux capacity has not been 
reported. In contrast, IGFBP3 was reported to decrease inflammation by inhibiting the JNK 
and nuclear factor-κB pathways.22) In addition, IGFBP3 attenuates tumor necrosis factor-
α-mediated apoptosis in microvascular endothelial cells.23) However, a previous study 
showed that blood IGFBP3 levels are correlated with carotid intima-media thickness24); thus, 
the role of this protein in atherosclerosis requires clarification. Originally identified as a 
neuroprotective factor, pigment epithelium-derived factor (PEDF) influences angiogenesis 
and apoptosis in multiple cell types.25) Blood PEDF levels, which can be elevated by a counter-
regulatory response, were associated with vascular inflammation and carotid intima-media 
thickness.26) Interestingly, PEDF was reported to inhibit endothelial activation by suppressing 
the generation of reactive oxygen species.27) In our study, PEDF was weakly related to 
cholesterol efflux capacity, suggesting that this protein is involved in vascular protection.
In this study, apoA1, the most abundant protein in HDL, was not ranked highly as a 
differentially abundant protein for HDL functions. Although the level of this protein is 
much greater than that of other high-ranked proteins, its lack of functional associations may 
explain the smaller difference between apoA1 levels in HDLs with the highest and lowest test 
values. ApoA4 was 1.44-fold more abundant in the highest quartile group of cholesterol efflux 
capacity, while other apoAs did not show difference according to cholesterol efflux capacity 
groups either. With regard to NO production and VCAM-1 expression, no apoAs revealed 
significant difference depending on the functional property of HDL.
This study had some limitations. First, clinical risk factors could not be adjusted during 
the analysis. However, most risk factors were similar between sample groups, except 
for marginal differences in age and cholesterol levels. Second, elucidation of the action 
mechanism of proteins was beyond the scope of our study. For instance, for some proteins, 
such as thyroxine-binding globulin, alpha-1B-glycoprotein, plasma serine protease inhibitor, 
and angiotensinogen, a role in cholesterol efflux or inflammation remains to be suggested. 
Further studies are needed to confirm the roles of these proteins. Third, we did not analyze 
lipid component of HDL. However, the focus of our study was proteomic analysis, and we 
obtained appropriate results. Because lipid composition can be associated with biological 
function of HDL,28) lipidomic analysis might have added further information to our 
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results. Fourth, we did not separately analyze subfractions of HDL. Although comparison 
of subfractions, such as HDL2 or HDL3, could provide some additional data, it was not 
necessary for the purpose of our study that was to investigate associations between multiple 
HDL proteins and parameters of HDL function. In previous studies, researchers used total 
HDL3)7) or HDL subfractions6) according to their aims.
In summary, in this study, proteins showing greater or lower abundance in HDLs with high 
functional capacities were identified and ranked. Nine HDL proteins were newly identified as 
being linked to the cholesterol efflux capacity of HDL. Proteins abundant in HDL with high 
functional parameters belonged to diverse biological categories.
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